United States Securities and Exchange Commission
June 14, 2021
Page 4 of 9
14. | You present on page 57 what appears to be a non-GAAP income statement that reconciles to NOI, with greater prominence than your separate reconciliation of NOI on page 58. In this regard, please tell us how you considered Question 102.10 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations. |
Response: The Company acknowledges the Staff’s comment and has revised pages 56, 57 and 58 so that the reconciliation of NOI precedes the non-GAAP income statement that reconciles to NOI.
FFO, Core FFO and AFFO, page 59
15. | Please revise to clarify whether you define FFO in accordance with the NAREIT definition. |
Response: The Company acknowledges the Staff’s comment has revised page 59 to clarify that the Company does define FFO in accordance with the NAREIT definition.
Debt, Derivatives and Hedging Activity
Reference Rate Reform, page 66
16. | We note your disclosure that you have contracts indexed to LIBOR. Please revise to qualitatively and quantitatively disclose whether or not you have identified a material exposure to risks associated with the termination of LIBOR, and clarify whether your material contracts have a clearly defined alternative reference rate after the discontinuation of LIBOR. In this regard we note approximately $327.7 million of your outstanding debt at December 31, 2020, your $320 million notional amount of interest swaps expiring in 2024 and 2025, and your JPM Facility with an additional $320 million outstanding at March 31, 2021, all reference LIBOR. |
Response: The Company acknowledges the Staff’s comment and has revised page 40 to disclose the material exposure to risks associated with the termination of LIBOR and to clarify that the Company’s material contracts do not have clearly defined alternative reference rates after the discontinuation of LIBOR.
Executive Compensation
Compensation of Our Executive Officers in 2020, page 85
17. | We note that you intend to reimburse your advisor for all of its operating expenses and offering expenses. Please specifically disclose whether you will reimburse your advisor for the salaries and benefits to be paid to your named executive officers. |
Response: The Company acknowledges the Staff’s comment and has revised page 85 to clarify that the Adviser is not reimbursed for salary and benefits paid to the Company’s named executive officers.
18. | We note your grants of restricted stock units under your 2018 LTIP. Please revise to disclose the material terms of these awards, such as the applicable performance criteria or any conditions to exercisability, per by Item 402(o) of Regulation S-K. |
Response: The Company acknowledges the Staff’s comment and has revised pages 85 and 86 to disclose the material terms of the restricted stock units under the Company’s LTIP.
Description of Registrant’s Securities to Be Registered
Share Repurchase Program, page 116